Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

US Patent 9592304 · Granted Mar 14, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotoxins with albumin binding domain2025
Cross species single domain antibodies targeting mesothelin for treating solid t2024
M971 chimeric antigen receptors2023
Immunotoxins with albumin binding domain2023
Anti-mesothelin polypeptides and proteins2022
Combination therapy of immunotoxin and checkpoint inhibitor2021
Anti-BCMA polypeptides and proteins2021
M971 chimeric antigen receptors2020
Recombinant immunotoxin targeting mesothelin2020
Human monoclonal antibodies specific for CD222019
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes2019
Pseudomonas exotoxin A with less immunogenic B cell epitopes2018